HYPOTHALAMIC OBESITY
Clinical trials for HYPOTHALAMIC OBESITY explained in plain language.
Never miss a new study
Get alerted when new HYPOTHALAMIC OBESITY trials appear
Sign up with your email to follow new studies for HYPOTHALAMIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Daily injection trial aims to curb uncontrollable hunger in rare brain disorder
Disease control Recruiting nowThis study is testing whether a daily injection called setmelanotide can help people aged 4 and older with a rare form of obesity caused by brain injury (hypothalamic obesity). Participants will receive either the real drug or a placebo for 26 weeks to see if it safely reduces bo…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New hope for rare obesity syndromes? weekly injection trial begins
Disease control Recruiting nowThis study is testing how well a weekly weight loss medication called tirzepatide works for one year in young adults (ages 18-26). It aims to compare its effects in people with rare, hard-to-treat obesity from genetic conditions like Prader-Willi Syndrome against those with gener…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE4 • Sponsor: Grace Kim • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Weekly shot aims to tame hunger and control weight in rare obesity disorders
Disease control Recruiting nowThis study is testing a new weekly injection called RM-718 to see if it is safe and can help control weight and hunger. It will involve about 150 people, including adults with general obesity and patients with obesity due to specific conditions like Prader-Willi Syndrome or brain…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE1, PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC